Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit - Reuters
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMlBfbG1yY051SHNUNHdybEJTNEt2VHowMk9UMy1abmpqWnRONG1QNVFKODluMi00Y3NLN2V4ejNxTWZrRGVRc3NGVkRYbVdDRFZJM1VvTktuQzAwTnBIRzlnOUJJQW9STHJzNVh1VmhWalVlcTNudGVIMzQ2ck1kTVBhV3E1RTBReEJpbm8taVZlc0tKLS10d2NEOWhxdUd6RXV4VjFqQUYxNm9VdFdNQWp6OHZpbE1P?oc=5" target="_blank">Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMHumana agrees not to reference Teva's Israel ties at US drug trial - Reuters
Humana agrees not to reference Teva's Israel ties at US drug trial Reuters
August 13, 2026 at 03:33 PM